Yatharth Hospital & Trauma Care Services Limited announced a robust start to FY27, reporting its highest-ever quarterly revenue of ₹3,927 million, a 51% increase year-on-year. The company also achieved record profits, with EBITDA growing 39% year-on-year, driven by strong performance from its newer hospitals and an improved payer mix. The company’s strategic expansion and operational efficiency are contributing to significant financial growth.
Record Financial Performance in Q1 FY27
Yatharth Hospital & Trauma Care Services Limited has reported exceptional financial results for the first quarter of Fiscal Year 2027 (Q1 FY27), ending June 30, 2026. The company achieved its highest-ever quarterly revenue, reaching ₹3,927 million, representing a substantial 51% increase compared to the same period last year and a 15% growth quarter-on-quarter. This remarkable growth underscores the effectiveness of the company’s strategic initiatives and operational scaling.
Key Financial Highlights
The company’s profitability also saw significant improvement, with EBITDA growing by 39% year-on-year. This performance is attributed to the strong growth strategy implemented over recent quarters, leading to enhanced operating leverage. The adjusted EBITDA margin, excluding the impact of newer facilities, stood at a healthy 28.1%.
Newer Hospitals Drive Growth
The contribution from newer hospitals, including those in Greater Faridabad, New Delhi Faridabad Sector 20, and Agra, was notable, accounting for 27% of the total revenue. The Faridabad Sector 20 hospital achieved EBITDA breakeven within an impressive 9 months of its operation, generating a monthly revenue rate of ₹12-13 crores with an ARPOB close to ₹40,000. The New Delhi hospital is also performing strongly, nearing an ARPOB of ₹50,000.
Capacity Expansion and Future Outlook
Yatharth Hospitals remains committed to its expansion roadmap, with plans to double its bed capacity to 5,000 beds over the next few years. The upcoming Gurugram facility, expected to be operational by Q1 of the next fiscal year, will further bolster the company’s presence in the premium NCR market. The company is confident about entering an exciting phase of growth, focusing on improving utilization and driving earnings.
Interim Dividend and ESOPs
In recognition of its strong performance, the Board approved a maiden interim dividend of 5% of face value. Additionally, the company launched its first ESOP scheme, ‘ESOP Scheme 2026,’ to attract, retain, and align quality talent, reflecting confidence in its business model and a commitment to sharing value with its stakeholders.
Source: BSE
